Genexine
About
What does Genexine do?
Genexine is a biopharmaceutical company dedicated to developing innovative biologics to address serious health issues and improve patient lives. They focus on creating novel immunotherapies for cancer and antibody therapies for rare diseases, utilizing proprietary platforms like the long-acting hyFc® Fusion Platform and DNA Vaccine Platform. Their pipeline includes treatments for anemia, growth hormone deficiency, and cervical cancer, aiming to save lives through scientific innovation.
What is Genexine's revenue?
StartupHub estimates Genexine's annual revenue at $22.1M (range $7.2M to $57.1M, 33% confidence), based on comparable companies in the sector.
What is Genexine's valuation?
StartupHub estimates Genexine's effective valuation at $1.2B (range $741.3M to $1.8B, 10% confidence), based on comparable companies in the sector.
How much funding has Genexine raised?
Genexine has raised a total of $297M in funding. The most recent round on record is Funding.
Where is Genexine headquartered?
Genexine is headquartered in Seoul, South Korea.
When was Genexine founded?
Genexine was founded in 1999.
What industry does Genexine operate in?
Genexine operates in Biotechnology, HealthTech, Drug Discovery, Immunotherapy, Oncology, Rare Diseases.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.